Promotional price valid on web orders only. Your contract pricing may differ. Interested in signing up for a dedicated account number?
Learn More
  1. Home
  2. Products
  3. 5000412775

Medchemexpress LLC Ethosuximide-d3 | 1189703-33-0 | ≥99.0% | 1 MG
SDP

Catalog No. 5000412775
Encompass_Preferred

Ethosuximide-d3 is the deuterium labeled Ethosuximide. It is a widely prescribed anti-epileptic agent that improves the phenotypes of multiple neurodegenerative disease models and blocks the low voltage activated T-type calcium channel. It can be used as a tracer and as an internal standard for quantitative analysis by NMR, GC-MS, or LC-MS. Deuteration has gained attention because of its potential to affect the pharmacokinetic and metabolic profiles of drugs.

  • Deuterium labeled ethosuximide.
  • Can be used as a tracer.
  • Can be used as an internal standard for quantitative analysis by NMR, GC-MS, or LC-MS.
  • Improves phenotypes of multiple neurodegenerative disease models.
  • Blocks low voltage activated T-type calcium channel.
  • Deuterium substitution can affect pharmacokinetic and metabolic profiles of drugs.

Catalog No. 50-004-12775 Supplier Medchemexpress LLC Supplier No. HYB1378S1MG
May include imposed supplier surcharges.
Add to Cart
Add to Cart

missing translation for 'validMainframeMsg'

Ethosuximide-d3 is the deuterium labeled Ethosuximide. It is a widely prescribed anti-epileptic agent that improves the phenotypes of multiple neurodegenerative disease models and blocks the low voltage activated T-type calcium channel. It can be used as a tracer and as an internal standard for quantitative analysis by NMR, GC-MS, or LC-MS. Deuteration has gained attention because of its potential to affect the pharmacokinetic and metabolic profiles of drugs.

  • Deuterium labeled ethosuximide.
  • Can be used as a tracer.
  • Can be used as an internal standard for quantitative analysis by NMR, GC-MS, or LC-MS.
  • Improves phenotypes of multiple neurodegenerative disease models.
  • Blocks low voltage activated T-type calcium channel.
  • Deuterium substitution can affect pharmacokinetic and metabolic profiles of drugs.

Product Title
Select an issue

By clicking Submit, you acknowledge that you may be contacted by Fisher Scientific in regards to the feedback you have provided in this form. We will not share your information for any other purposes. All contact information provided shall also be maintained in accordance with our Privacy Policy.